Aggressive cutaneous squamous cell carcinoma in a patient on Janus-kinase inhibitor therapy

• Ana M. Aragon Sierra, MD,
• Kevin J. Donohoe, MD,
• Daniel J. Canaday, MD,
• Ernest D. Gomez, MD,
• Scharukh M. Jalisi, MD,
• Matthew M. Koomey, MD,
• Victor M. Aviles, MD,
• Kenneth K. Yu, MD, PhD

Affiliations

Ana M. Aragon Sierra, MD

Cambridge Health Alliance, Cambridge, Massachusetts; Harvard Medical School, Boston, Massachusetts

Kevin J. Donohoe, MD

Harvard Medical School, Boston, Massachusetts; Beth Israel Deaconess Medical Center, Boston, Massachusetts

Daniel J. Canaday, MD

Harvard Medical School, Boston, Massachusetts; Beth Israel Deaconess Hospital – Plymouth, Plymouth, Massachusetts

Ernest D. Gomez, MD

Harvard Medical School, Boston, Massachusetts; Beth Israel Deaconess Medical Center, Boston, Massachusetts

Scharukh M. Jalisi, MD

Harvard Medical School, Boston, Massachusetts; Beth Israel Deaconess Medical Center, Boston, Massachusetts

Matthew M. Koomey, MD

Harvard Medical School, Boston, Massachusetts; Beth Israel Deaconess Hospital – Plymouth, Plymouth, Massachusetts

Victor M. Aviles, MD

Hematology Oncology Specialists of Cape Cod, North Falmouth, Massachusetts

Kenneth K. Yu, MD, PhD

Cambridge Health Alliance, Cambridge, Massachusetts; Harvard Medical School, Boston, Massachusetts; Beth Israel Deaconess Medical Center, Boston, Massachusetts; Beth Israel Deaconess Hospital – Plymouth, Plymouth, Massachusetts; Plymouth Dermatology Associates, Plymouth, Massachusetts; Correspondence to: Kenneth K. Yu, MD, PhD, Division of Dermatology, Cambridge Health Alliance, 236 Highland Ave, Somerville, MA 02143.